Benchmark Holdings PLC
LSE:BMK
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
34
48
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Benchmark Holdings PLC
Benchmark Holdings PLC
Research & Development
Benchmark Holdings PLC
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Benchmark Holdings PLC
LSE:BMK
|
Research & Development
-£10.5m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Nomad Foods Ltd
NYSE:NOMD
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Associated British Foods PLC
LSE:ABF
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Premier Foods PLC
LSE:PFD
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cranswick PLC
LSE:CWK
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Tate & Lyle PLC
LSE:TATE
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Benchmark Holdings PLC
Glance View
Benchmark Holdings Plc engages in the provision of applied biotechnology, sustainability research, and other related services to aquaculture, agriculture, and food sector. The company is headquartered in Sheffield, South Yorkshire and currently employs 796 full-time employees. The company went IPO on 2013-12-18. The Company’s segments include Genetics, Advanced Nutrition and Health. The Genetics segment is salmon breeding technology combined with state-of-the-art production facilities to provide a range of genetic merit ova. Advanced Nutrition segment manufactures and provides nutrition and health products to the global aquaculture industry. The Health segment is focused on providing health products to the global aquaculture market. The firm has a portfolio of products and solutions, including salmon eggs with specialist genetic traits, shrimp broodstock, tilapia fry, technology enhanced live feed (Artemia), specialist diets, probiotics and sea lice treatments.
See Also
What is Benchmark Holdings PLC's Research & Development?
Research & Development
-10.5m
GBP
Based on the financial report for Jun 30, 2024, Benchmark Holdings PLC's Research & Development amounts to -10.5m GBP.
What is Benchmark Holdings PLC's Research & Development growth rate?
Research & Development CAGR 3Y
-38%
Over the last year, the Research & Development growth was -62%. The average annual Research & Development growth rates for Benchmark Holdings PLC have been -38% over the past three years .
You don't have any saved screeners yet
